Clofibrate
From Wikipedia, the free encyclopedia
Clofibrate
|
|
Systematic (IUPAC) name | |
ethyl 2-(4-chlorophenoxy)-2-methylpropanoate | |
Identifiers | |
CAS number | |
ATC code | C10 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C12H15ClO3 |
Mol. mass | 242.698 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | Variable, 92–97% at therapeutic concentrations |
Metabolism | Hydrolyzed to clofibric acid; hepatic glucuronidation |
Half life | Highly variable; average 18–22 hours. Prolonged in renal failure |
Excretion | Renal, 95 to 99% |
Therapeutic considerations | |
Pregnancy cat. | |
Legal status | |
Routes | Oral |
Clofibrate (tradename Atromid-S) is a fibrate. Clofibrate is a lipid lowering agent used for controlling the high cholesterol and triacylglyceride level in the blood. It increases lipoprotein lipase activity to promote the conversion of VLDL to LDL, and hence reduce the level of VLDL. It is proved that it can increase the level of HDL as well.
Can induce SIADH
|